Inside Innovation: BioLabs Pegasus Park
Building the Infrastructure of Innovation
|
Exploring the people, ideas, and breakthroughs shaping the North Texas life sciences ecosystem.
The latest episode, “Building the Infrastructure of Innovation,” features Dr. Gabby Everett, Director of Business Operations & Strategy, Site Head at BioLabs Pegasus Park. Together, they explore how BioLabs is empowering early-stage biotech companies with the space, tools, and community they need to accelerate growth—and how the Pegasus Park campus has become a national model for innovation infrastructure.
“BioLabs is where ideas become companies,” says Eric B. Moore. “This episode is about what it takes to create an ecosystem that truly supports that journey—from shared equipment and mentorship to the power of community.”
Because in North Texas, innovation is not only happening—it is accelerating.
|
UTA & TEES Expand Life Science Innovation
with Pegasus Park Biomanufacturing Hub
|
(left to right) Logan Ardrey of NCTM, Councilwoman Laura Cadena of Dallas City Council District 6, Baley Reeves, PhD of NCTM,
Lyda Hill of Lyda Hill Philanthropies, Rodney Bowersox, PhD, MS of Texas A&M Engineering Experiment Station, Jennifer Cowley, PhD, MS, MPA, FAICP of UTA,
Arum Han, PhD, MS of Texas A&M College of Engineering, Kate Miller, PhD of UTA and Jon Weidanz, PhD, MPH of UTA
|
Jon Weidanz, PhD, MPH of UTA
|
Community leaders tour
the new NCTM2 facility
|
The University of Texas at Arlington (UTA) and the Texas A&M Engineering Experiment Station (TEES) have opened the National Center for Therapeutics Manufacturing satellite campus (NCTM2) at Pegasus Park—marking a major step forward for North Texas' biomanufacturing and workforce development capabilities.
Located inside Bridge Labs, the new 5,000-square-foot hub will provide hands-on training, state-of-the-art lab space, and support for biotech startups. The center is a joint initiative of UTA’s IMPRINT Institute and TEES, aimed at expanding the region’s capacity to train talent and accelerate innovation.
“Together, we are building the backbone of Texas’ next-generation biomanufacturing ecosystem and positioning North Texas as a national leader to produce the medicines of the future,” said Jon Weidanz, UTA’s senior associate vice president for research and founding director of IMPRINT.
NCTM2 supports a national push to strengthen domestic biomanufacturing and will help position North Texas as a key contributor to the emerging U.S. bioeconomy.
|
UNT Dallas Celebrates Grand Opening of New STEM Building
|
University leaders, elected officials, and community partners marked the ribbon-cutting of UNT Dallas’ new STEM building, which will open for Spring semester classes on January 12, 2026. Completed on time and under budget, the four-story facility reflects the university’s mission to expand opportunities and meet urgent workforce needs in healthcare and STEM fields.
The cutting-edge building features 18 classrooms, 12 laboratories, collaborative spaces, faculty offices, and a large event venue. Academic programs at launch include biology, chemistry, mathematics, and neuroscience, preparing students for careers in medicine, nursing, pharmacy, dentistry, and optometry.
|
Strengthening the Region’s Innovation Pipeline:
TechFW Unveils Its New Brand
|
A thriving ecosystem depends on strong connectors—organizations that bring founders, investors, researchers, and community partners together to spark collaboration and accelerate innovation. TechFW has long played that role in Fort Worth, and its latest milestone underscores just how important this work is to the future of North Texas.
TechFW recently convened founders, Cowtown Angels investors, biotech innovators, county leaders, and university partners to celebrate the holidays and unveil the organization’s new brand, marking a major step forward in its commitment to supporting North Texas startups.
The rebrand reflects TechFW’s broader strategic evolution to better welcome and guide founders into Fort Worth’s innovation ecosystem. It introduces enhanced programming, a more cohesive and accessible startup pipeline, and a newly formalized biotech incubator track designed to strengthen emerging life science ventures.
As Fort Worth continues to grow as a hub for medical innovation, mobility, and advanced manufacturing, TechFW’s refreshed identity signals a bold, inclusive, and locally rooted vision for the future, one that aligns closely with BioNTX’s mission to cultivate a world-class regional bioeconomy.
|
Give Back This Season at Pegasus Park and BioLabs
Holiday Drive Collection Ending on December 19, 2025
|
BioLabs and Pegasus Park are collecting nonperishable items including boxed, canned, and shelf stable foods to support local organizations and community members who dedicate their time and energy to others throughout the year. Every can, box, and bag makes a difference. Your donations help nourish our neighbors and support those who keep our community thriving.
|
An Evening of Insight & Innovation:
The BioNTX 2025 Rising Star Investor Dinner
|
BioNTX recently held its Rising Star Investor Dinner at the Texas Research Quarter, bringing together investors with both current and past Rising Stars for an intimate evening of connection and meaningful conversation. The event served as a celebration of the groundbreaking work taking place across our region and the people who continue to push the life sciences industry forward.
We are deeply grateful to all of our Rising Stars for the impact, innovation, and vision they bring to North Texas. We also extend sincere appreciation to the investors who help advance science, fuel opportunity, and support the next generation of industry leaders. Your engagement strengthens the foundation of our ecosystem.
A special thank-you to our fireside chat guests—Kristen Doyle, CEO of CPRIT, and Eric Danielson, Managing Director and Head of Real Estate Development at NexPoint. Their insights set a powerful tone for the evening, highlighting the connectivity, shared purpose, and momentum that continue to define our community.
BioNTX congratulates all of our 2025 Rising Stars. Your leadership and perseverance reflect the very best of our region, and we look forward to championing your continued growth in the year ahead.
Thank you for your support
|
BioNTX Wraps Up the Year with
Three BIO BREAKs Across North Texas
|
BioNTX wrapped up the year by hosting three BIO BREAKs in Dallas, Fort Worth, and Frisco, bringing together the life science community to celebrate the season and connect with peers. These gatherings offered a fun and engaging way for innovators, entrepreneurs, and industry leaders to share experiences and reflect on a year of growth in the region’s thriving biotech ecosystem. Thank you to everyone who attended and for all the hard work being done to advance our industry.
Thank you for your support
|
Peer Career Connection Program:
Career Support & Networking for Job Seekers
January 14, 2026
|
Presents
2026 Peer Career Connection Program
|
BioNTX proudly introduces the 2026 Peer Career Connection Program (PCCP)—a supportive, community-driven initiative designed specifically for jobseekers navigating career transitions in the life sciences and beyond.
Held monthly on the 2nd Wednesday, PCCP provides a dedicated space to learn, share, and grow alongside peers who understand the realities of a changing career path. Together, we explore our journeys, the challenges we have faced, and the successes—big and small—that move us forward. In addition to individual career seekers, we invite BioNTX member companies to come and share information about what they are looking for in candidates.
Our BioNTX staff, partners, and member companies have all walked this road. We know the ups, downs, and uncertainties of the job search, and we’re committed to helping you build confidence, expand your network, and strengthen the skills that will lead you to your next opportunity.
PCCP welcomes jobseekers at every stage of transition—from early-career professionals to seasoned executives, and from industries as diverse as aerospace, biopharma, digital health, logistics, engineering, research, and manufacturing. Whether you are refining your résumé, exploring new sectors, or seeking meaningful community, you will find supportive peers and connections here.
Our members are people just like you—professionals seeking growth, community, and meaningful conversations.
Come network, learn, and take the next step toward your future.
|
CFO Forum: Expert Tax & Accounting
Guidance for Life Sciences
January 22, 2026
|
Earn CPE Credits and Strengthen Your Tax and Accounting Strategy
|
Join us to learn key tax and accounting strategies to help you prepare for growth and maximize opportunities around qualified small business stock (QSBS), R&D credits, state nexus, and more.
Connect with Baker Tilly experts who can help you navigate the financial complexities of building and scaling your life science company.
|
Thank you for your support
|
The BioNTX Career Symposium & HR Forum
February 11, 2026
|
Presents
2026 Career Symposium & HR Forum
|
The Career Symposium connects job seekers with industry professionals and recruiters shaping the future of life sciences and healthcare innovation. Explore networking opportunities, receive expert career guidance, and access resources to enhance your resume, and navigate your career path.
|
The HR Forum is designed for biotech and healthcare innovation employers seeking to navigate the complexities of workforce management. This forum also provides opportunities to explore emerging trends in human resources, share best practices, and connect with peers facing similar workforce challenges.
|
Thank you for your support
|
Women Driving Innovation:
Celebrating Leadership in Life Sciences
March 6, 2026
|
Presents
2026 Women Driving Innovation
|
In celebration of International Women’s Day, Women Driving Innovation recognizes and celebrates women who are transforming the life sciences industry through visionary leadership, creativity, and groundbreaking research.
The program highlights the importance of collaboration, mentorship, and visibility, providing opportunities for women to connect, share knowledge, and inspire one another. By empowering the next generation of life sciences leaders, Women Driving Innovation is helping to shape an inclusive future for North Texas and beyond.
|
Turning Vision into Built Reality
|
Structure Tone Southwest has delivered full-service general contracting since 1977, offering expertise in construction management, interior build-outs, renovations, and large-scale ground-up projects. They manage projects of all sizes throughout the Southwest, providing comprehensive planning, budgeting, scheduling, and construction solutions.
The company is committed to exceptional service and to giving back through programs, contributions, and volunteer efforts that support its employees and communities.
|
Lyda Hill Philanthropies Supports Efforts to
Boost Early-Stage Cancer Research
|
Lyda Hill Philanthropies is supporting the Cancer Prevention Initiative in Dallas to advance early-stage research into hereditary cancers. The initiative focuses on inherited genetic mutations linked to various cancer types and works to develop vaccines, targeted therapies, and precision detection tools.
The Cancer Prevention Initiative addresses hereditary cancers, which account for 5% to 10% of diagnoses, and prioritizes research into more than 50 known inherited mutations. Lyda Hill Philanthropies’ support reflects a commitment to innovative cancer solutions, community health, and fostering medical research and entrepreneurship in Texas.
|
The Startup Mindset Driving
Healthcare Innovation with Dr. Hubert Zajicek
|
In this episode of Acuity + Acumen, Deanna Armstrong speaks with Dr. Hubert Zajicek, CEO and co-founder of Health Wildcatters, a leading healthcare accelerator.
Dr. Zajicek shares his journey from physician to healthcare innovator and explores how mentorship, collaboration, and a commitment to excellence are driving breakthrough startups in North Texas.
|
Island Pharmaceuticals Secures US Patent for
Galidesivir in COVID-19 Treatment
|
Island Pharmaceuticals Ltd has been granted a U.S. patent for the use of Galidesivir in treating SARS-CoV-2, extending protection through July 2042. This strengthens the company’s IP portfolio and supports Galidesivir’s potential as a broad-acting antiviral, aligning with Island’s strategy to progress its regulatory pathway for Marburg virus treatment.
|
Lantern Pharma Announces Positive Phase 1a Results for LP-184
|
Lantern Pharma Inc. announced new details from its completed Phase 1a study of LP-184, which showed encouraging durable disease control in 63 heavily pre-treated patients with advanced solid tumors. The trial met all safety and tolerability endpoints and established a clear recommended Phase 2 dose.
Lantern is now advancing multiple biomarker-guided Phase 1b/2 trials in TNBC, GBM, NSCLC, and bladder cancer. The company estimates the market opportunity for LP-184 could exceed $10 billion annually.
|
NanOlogy Announces Development Program for DIPG Treatment
|
NanOlogy, LLC is developing LSAM-Cisplatin, a locally delivered intratumoral therapy aimed at improving outcomes for children with diffuse intrinsic pontine glioma (DIPG), an aggressive pediatric brainstem tumor. The company is completing FDA-required IND-enabling studies and plans to submit its IND application for malignant brain tumors, with a goal of initiating a pediatric clinical trial in late 2026.
|
Solenic Medical Uses AMF Technology in
First FDA-Authorized Compassionate Use Case
|
Solenic Medical’s investigational Alternating Magnetic Field (AMF) technology was used for the first time under FDA-authorized compassionate use to treat a patient with a prosthetic joint infection (PJI). The noninvasive treatment, delivered alongside surgery, has progressed positively with no device-related adverse events reported. This follows Solenic’s completed human feasibility safety study, which also reported no device-related issues.
|
Avantor Wins 2025 Edison Patent Award for
Sustainable Viral Inactivation Technology
|
Avantor, Inc., a global provider of life sciences products and services, announced that, in partnership with Amgen, the company received a 2025 Edison Patent Award. The award recognizes the development of a biodegradable detergent that enables safer, more sustainable viral inactivation in biomanufacturing.
The detergent effectively inactivates viruses while preserving protein integrity and improving process yield, providing a compliant and environmentally responsible solution for producing monoclonal antibodies, vaccines, and gene therapies.
|
Baker Tilly Named Sage Intacct Partner
of the Year for 12th Consecutive Year
|
Baker Tilly, a leading advisory, tax, and assurance firm, has been recognized as Sage Intacct Partner of the Year in North America for the 12th consecutive year. The award highlights exceptional performance in sales, implementation, and customer service within Sage’s valued-added reseller community.
Baker Tilly leverages Sage products to deliver tailored solutions across industries including healthcare, not-for-profit, SaaS & technology, construction, and home and commercial services, combining deep product expertise with strategic insight to serve as a trusted advisor in the Sage Intacct ecosystem.
|
Caidya Expands Partnership with Medidata
to Accelerate Clinical Trials Using AI
|
Caidya, a leading global mid-sized clinical research organization (CRO), has expanded its partnership with Medidata, a Dassault Systèmes brand and provider of clinical trial solutions, by investing in additional Medidata solutions, including the Clinical Trial Management System (CTMS) and Clinical Data Studio. With Medidata already supporting over 80% of its trials, Caidya is positioned to better connect workflows, data, and teams across the trial lifecycle, enabling more data-driven decisions across a variety of therapeutic areas.
|
DFW Airport Drives Jobs and Growth Across North Texas
|
Dallas Fort Worth International (DFW) Airport now supports over 684,000 jobs and continues to be a key driver of growth, connectivity, and opportunity across North Texas, according to a new study by The Perryman Group.
Since 2014, the airport has expanded its services, increased passenger traffic, and strengthened the regional business landscape. With a major expansion underway, including new terminals and gates, DFW is preparing to serve 100 million passengers annually, ensuring the region remains a hub for commerce, tourism, and innovation.
|
Turner Construction Recognized by Forbes
as One of America’s Dream Employers
|
Turner Construction Company has been recognized by Forbes as one of Americas Dream Employers, celebrating its inspiring workplace and active caring culture. Turner provides employees with meaningful work building hospitals, data centers, and stadiums, along with career development, continuous learning, and access to cutting edge tools. With a culture of inclusion and collaboration, Turner is a place where people can grow, contribute, and make a difference.
|
UT Dallas Researchers Uncover Mechanism
That Strengthens Neural Connections
|
Hajira Elahi, PhD, MS and Ted Price, PhD
|
Researchers from The University of Texas at Dallas’ Center for Advanced Pain Studies (CAPS) and collaborators have discovered a fundamental mechanism that strengthens connections in the nervous system, with implications for learning, memory, and pain.
The team found that following an injury, presynaptic neurons release vertebrate lonesome kinase (VLK), which phosphorylates the extracellular side of ephrin type-B receptor 2 (EphB2). This process attracts N-methyl-D-aspartate (NMDA) receptor proteins, enhancing synaptic connections.
|
UT Southwestern Researchers Reveal Key Insights
in Neurology and Cardiovascular Health
|
UT Southwestern researchers have uncovered findings with major implications for movement disorders, cardiovascular disease, and Alzheimer’s. In essential tremor, patients’ cerebellums showed about 15% fewer Purkinje cells, offering new clues for treatment. Analysis of over 87,000 patients found that GLP-1 receptor agonists significantly reduce heart failure hospitalizations and cardiovascular deaths in patients with multiple conditions. In Down syndrome, Alzheimer’s-related changes appear as early as age 11, providing a path for early detection and intervention.
These discoveries advance understanding of disease mechanisms and potential strategies to improve patient care.
|
FUNDING & MENTORSHIP OPPORTUNITIES
|
Deadline Approaching: Apply for UT Dallas GDI Program
Application closes December 31, 2025
|
The Naveen Jindal School of Management at the University of Texas at Dallas GDI Program is currently a FREE program for qualified and selected foreign companies planning to enter the USA market, is a practicum (50% of an undergraduate class focused on Market Entry Strategies) offered by the school. The 13-week Market Research project is focused on providing market research for foreign-based companies interested in establishing operations in the USA to serve the USA and North American market. The class is held in both the fall and spring semesters and is required for students to earn a B.S. in Global Business.
|
Fueling the Next Generation of Health Innovators
Application closes March 6, 2026
|
The One Health Incubator is a dynamic partnership between the Innovation Hub and the Health Sciences Center, created to support researchers and technology startups in the life sciences sector. This collaborative platform combines institutional expertise to offer an ecosystem of incubation, mentorship, and strategic connections—tailored specifically for life science innovators.
Startups and researchers benefit from access to state-of-the-art facilities, specialized resources, and guidance from industry experts. The incubator helps accelerate the development and commercialization of innovative healthcare solutions while fostering valuable relationships with potential partners, investors, and mentors.
|
NIH Academic Research Enhancement Award (AREA)
for Undergraduate-Focused Institutions
Program ends January 8, 2027
|
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions.
|
Upcoming Events & Opportunities
|
JPM Healthcare Conference 2026
Join JPM for their 44th annual event. This premier conference is the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
January 12th - 15th | San Francisco, CA
|
Presents
Peer Career Connection Program (PCCP)
The Peer Career Connection Program (PCCP) is a community-driven initiative for jobseekers navigating career transitions in life sciences and beyond. PCCP provides a space to learn, share, and grow alongside peers, exploring challenges, successes, and career journeys.
January 14th | Dallas, TX
|
What is Next for North Texas Healthcare 2026
Join Healthcare Think Tank for an an inside look at what is next for North Texas healthcare and predictions for 2026.
January 20th | Dallas, TX
|
Presents
CFO Forum
Join us to learn key tax and accounting strategies to help you prepare for growth and maximize opportunities around R&D credits, state nexus, and more.
January 22nd | Dallas, TX
|
Biotechnology Career Fair 2026
Join the National Center for Therapeutics Manufacturing (NCTM) and the International Society for Pharmaceutical Engineering (ISPE) student chapter at Texas A&M for the first annual Biotechnology Career Fair in Spring 2026.
January 23rd | College Station, TX
|
Q1 2026 BHIANT Quarterly Meeting
Join the BHIANT for their fourth quarterly meeting of 2026. Meet with other industry leaders and collaborate to tackle pressing challenges, redefine shared goals, and strengthen the biotech and healthcare ecosystem across North Texas.
January 27th | TBD
|
Thank you for your Support!
"I was taught the way of progress is neither swift nor easy."
- Dr. Marie Cure
|
|